Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharma (DUL) Q1 2025 Earnings Report

0 Followers

CH:DUL Q1 2025 EPS Results

Actual EPS
-CHF 0.37
Consensus EPS
-CHF 0.75
Beat/Miss
Beat by +CHF 0.38
One Year Ago EPS
-CHF 0.44

CH:DUL Q1 2025 Revenue Results

Actual Revenue
CHF 498.60M
Expected Revenue
CHF 491.01M
Beat/Miss
Beat by +CHF 7.59M
YoY Revenue Growth
+20.20%

Earnings Announcement Details

Quarter
Q1 2025
Date
05/01/2025
Time
Before Open
Conference Call
Thursday, May 1, 2025
CH:DUL Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q1 2025 Earnings Call Audio

CH:DUL Q1 2025 Earnings Call
0:00 / 0:00

Q1 2025 Earnings Slide Deck

Q1 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:DUL Earnings History

CH:DUL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)1.44-0.69――
Oct 29, 20262026 (Q3)1.3913.191.54754.35% (+11.65)
Jul 30, 20262026 (Q2)1.371.02-0.43337.25% (+1.44)
Apr 30, 20262026 (Q1)0.731.27-0.37443.18% (+1.64)
Feb 12, 20262025 (Q4)0.970.69-0.55226.15% (+1.23)
Oct 30, 20252025 (Q3)0.471.54-0.73311.49% (+2.27)
Jul 31, 20252025 (Q2)-0.46-0.43-0.11-292.31% (-0.32)
May 01, 20252025 (Q1)-0.75-0.37-0.4415.38% (+0.07)
Feb 13, 20252024 (Q4)-0.50-0.55-0.9240.91% (+0.38)
Oct 31, 20242024 (Q3)-0.77-0.730.97-175.65% (-1.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed